NEW APPROACHES FOR TREATMENT IN DIABETES - ALDOSE REDUCTASE INHIBITORS

被引：57

作者：

HOTTA, N

机构：

[1] The Third Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya, 466

来源：

BIOMEDICINE & PHARMACOTHERAPY | 1995年 / 49卷 / 05期

关键词：

POLYOL PATHWAY; DIABETIC COMPLICATIONS; NEUROPATHY; RETINOPATHY; ATHEROSCLEROSIS; INFECTION; NEUTROPHIL FUNCTION; RED BLOOD CELL 2,3-DIPHOSPHOGLYCERATE;

D O I：

10.1016/0753-3322(96)82629-1

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：232 / 243

页数：12

共 170 条

[1]

AKAGI Y, 1988, POLYOL PATHWAY ITS R, P237

[2]

ALBERTI KGM, 1972, LANCET, V2, P391

[3]

ALTOMONTE L, 1980, IRCS MED SCI-BIOCHEM, V8, P318

[4]

AO S, 1990, CURRENT CONCEPTS ALD, P81

[5]

AO S, 1990, CURRENT CONCEPTS ALD, P221

[6]

AWATA T, 1986, JPN J OPHTHALMOL, V30, P245

[7] IMPAIRED LEUKOCYTE FUNCTION IN PATIENTS WITH POORLY CONTROLLED DIABETES [J].

BAGDADE, JD ;

ROOT, RK ;

BULGER, RJ .

DIABETES, 1974, 23 (01) :9-15

[8]

BAGNASCO S, 1986, J BIOL CHEM, V261, P5872

[9] OSMOREGULATION BY SLOW CHANGES IN ALDOSE REDUCTASE AND RAPID CHANGES IN SORBITOL FLUX [J].

BAGNASCO, SM ;

MURPHY, HR ;

BEDFORD, JJ ;

BURG, MB .

AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (06) :C788-C792

[10] THE POLYOL PATHWAY, SORBINIL, AND RENAL DYSFUNCTION [J].

BEYERMEARS, A .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04) :46-54

← 1 2 3 4 5 6 7 8 9 10 →